TrialBMC cancer2022

Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).

Sotaro Sadahiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.